@entity65 is the most common cause of @entity204 in @entity1 and @entity1 worldwide. @entity1 develop most, but not all, @entity65 at an earlier age while the number of affected @entity1 significantly increases with higher age. @entity712 ( @entity712 ) is a common cause of @entity65 and carries a poor prognosis in both genders. Risk factors and @entity296 in @entity712 in @entity1 and @entity1 are different. Female hearts develop a more favorable physiological form of myocardial remodeling than male hearts. This may be related to sex hormones, @entity172 and @entity251 . A clinical study for gender differences in @entity1 @entity472 supports the hypotheses. @entity712 management differs between both sexes, with underdiagnosis and undertreatment and less use of invasive therapies in @entity1 . Nevertheless, @entity1 frequently have better outcomes than @entity1 . Gender research will contribute directly to @entity1 -oriented benefit by suggesting clinical protocols.

Sex and gender differences in myocardial hypertrophy and XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'human', 'patient', 'Men', 'men'] @entity172 :: ('MESH:D004967', 'Chemical') :: ['estrogens'] @entity251 :: ('MESH:D013739', 'Chemical') :: ['testosterone'] @entity712 :: ('MESH:D006333', 'Disease') :: ['HF', 'Heart failure'] @entity296 :: ('MESH:D009202', 'Disease') :: ['myocardial adaptations'] @entity472 :: ('MESH:D001024', 'Disease') :: ['aortic stenosis'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity65 :: ('MESH:D002318', 'Disease') :: ['Cardiovascular disease', 'cardiovascular death', 'cardiovascular diseases']
@entity712 :: (MESH:D006333,Disease) :: ['heart failure']
